Kalkine has a fully transformed New Avatar.
Centene Corporation
CNC Details
Centene Corporation (NYSE: CNC) is a multi-national healthcare company that participates in government-sponsored and commercial healthcare programs to cater to under-insured and uninsured individuals. Its revenue-generating segments include 1) Managed Care segment, focused on providing health plans, including all of the functions required to operate them, and 2) Specialty Services segment, comprising supplementary healthcare products and services. As of November 15, 2021, CNC’s market capitalization stood at USD 43.82 billion.
Latest News:
Q3FY21 Results:
Key Risks:
Outlook:
Valuation Methodology: EV/EBITDA Multiple Based Relative Valuation
(Analysis by Kalkine Group)
* % Premium/(Discount) is based on our assessment of the company's NTM trading multiple after considering its key growth drivers, economic moat, stock's historical trading multiples versus peer average/median, and investment risks.
CNC Daily Technical Chart (Source: REFINITIV)
Stock Recommendation:
CNC's stock price has increased by 29.06% in the past nine months and is currently close to the higher end of its 52-week range of USD 57.16 to USD 76.17. The stock is currently trading above its 50 and 200 DMA levels, and its RSI Index is 67.67, indicating an overbought zone. We have valued the stock using the EV/EBITDA-based relative valuation methodology and arrived at a target price of USD 71.06.
Considering the significant uptick in the stock price and other technical indicators, we believe the decent business fundamentals are sufficiently reflected at current trading levels. Hence, we recommend a "Sell" rating on the stock at the closing price of USD 75.10, down 1.00% as of November 15, 2021.
* All forecasted figures and Industry Information have been taken from REFINITIV.
* The reference data in this report has been partly sourced from REFINITIV.
The St. Joe Company
JOE Details
The St. Joe Company (NYSE: JOE) is a Northwest Florida-based real estate development, asset management, and operating company. The company is focused on increasing the value of its real estate assets by constructing residential, commercial, and hospitality buildings. Nearly 86 percent of JOE's real estate is located in Florida's Bay, Gulf, and Walton Counties. In addition, approximately 90 percent of its property holdings are within 15 miles of the United States Gulf of Mexico. As of November 15, 2021, the company’s market capitalization stood at USD 3.12 billion.
Latest News:
Q3FY21 Results:
Key Risks:
JOE Daily Technical Chart (Source: REFINITIV)
Stock Recommendation:
JOE's share price has increased 72.11% in the past twelve months and is currently leaning towards the higher end of its 52-week range of USD 29.84 to USD 57.55. The stock is currently trading above its 50 and 200 DMA levels, and its RSI Index is at 72.04, representing an overbought zone.
Considering the significant uptick in the stock price and other technical indicators, we believe the solid business fundamentals are adequately reflected the current trading levels. Hence, we recommend a "Sell" rating on the stock at the closing price of USD 52.94, down 1.08% as of November 15, 2021.
*All forecasted figures and Industry Information have been taken from REFINITIV.
*The reference data in this report has been partly sourced from REFINITIV.
Disclaimer - This report has been issued by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and prepared by Kalkine and its related bodies corporate authorised to provide general financial product advice. Kalkine.com.au and associated pages are published by Kalkine.
Any advice provided in this report is general advice only and does not take into account your objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your objectives, financial situation and needs before acting upon it.
There may be a Product Disclosure Statement, Information Statement or other offer document for the securities or other financial products referred to in Kalkine reports. You should obtain a copy of the relevant Product Disclosure Statement, Information Statement or offer document and consider the statement or document before making any decision about whether to acquire the security or product.
You should also seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice in this report or on the Kalkine website. Not all investments are appropriate for all people.
The information in this report and on the Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of information contained in its reports, newsletters and websites. All information represents our views at the date of publication and may change without notice.
Kalkine does not guarantee the performance of, or returns on, any investment. To the extent permitted by law, Kalkine excludes all liability for any loss or damage arising from the use of this report, the Kalkine website and any information published on the Kalkine website (including any indirect or consequential loss, any data loss or data corruption). If the law prohibits this exclusion, Kalkine hereby limits its liability, to the extent permitted by law, to the resupply of services.
Please also read our Terms & Conditions and Financial Services Guide for further information.
On the date of publishing this report (referred to on the Kalkine website), employees and/or associates of Kalkine and its related entities do not hold interests in any of the securities or other financial products covered on the Kalkine website.
Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.